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Objective: To explore the association between combined lifestyle risk factors with quality
of life in people with multiple sclerosis (MS) over 2.5 years.
Methods: People with MS were recruited to participate in a comprehensive online
survey regarding their demographic and clinical characteristics, health-related quality of
life (HRQOL), and lifestyle behaviors including physical activity, alcohol consumption,
cigarette smoking, body mass index, and dietary habits measured at baseline and
2.5-year follow-up. A combined healthy lifestyle index score (HLIS) was constructed by
assigning scores of 0–4 to each of the lifestyle risk factors, for which higher values indicate
healthier lifestyle behavior. Multivariable linear regression modeling was used to assess
whether the HLIS at baseline was associated with the physical and mental HRQOL over
the study period in this sample of people with MS.
Results: Of 2,466 participants with confirmed MS, 1,401 (57%) completed the
follow-up. Multivariable linear regression analyses demonstrated that every 5-point
increase (of a possible total of 20) in the baseline HLIS was associated with 1.7 (95% CI:
0.2–3.2) and 2.5 (95% CI: 1.0–4.0) higher scores in the change in physical and mental
HRQOL components from baseline to follow-up respectively.
Conclusion: Findings suggest the importance of healthy lifestyle behavior in quality of
life in MS. A healthy lifestyle program focusing on these behaviors has the potential to
positively influence health-related quality of life for people with MS.
Keywords: multiple sclerosis, lifestyle, risk factors, quality of life, QOL, health outcomes
INTRODUCTION
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) that affects more
than 23,000 people in Australia (1). Characterized by areas of axonal injury and demyelination
in the CNS, MS can cause symptoms such as pain, fatigue, muscle weaknesses, impairments to
balance, vision, and cognition. All of these can significantly interfere with daily activities and affect
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health-related quality of life (HRQOL) (2). HRQOL is a
multidimensional measure that assesses physical, mental and
social functioning and how these domains are affected by disease.
The risk of MS is influenced by a complex interplay of genetic
and environmental risk factors (3–8). While susceptibility to
MS is influenced by genetics, environmental factors play an
important role in the risk for development and progression of the
disease. These environmental risk factors comprise of a number
of lifestyle risk factors, some of which can be potentially modified.
Several studies have established associations between
individual lifestyle risk factors such as physical activity (9),
dietary habits (10), BMI (11), alcohol consumption, and smoking
(12, 13) with HRQOL in MS. These findings were mostly limited
by the cross-sectional study design, which could not reveal the
dynamics of association (that is, they could not account for the
possibility of reverse causality). Few other studies have examined
direct associations of lifestyle risk factors with the progression of
MS in terms of HRQOL. One longitudinal study, which included
people with relapsing-remitting MS only, found associations
between physical activity and HRQOL (14). Another one-year
randomized controlled trial of a low-fat, plant-based diet found
a statistically significant association with the mental health
composite of HRQOL but no association with physical HRQOL
(15). Only a small sample of participants (n = 61) with limited
ethnic diversity were included in this study.
In this study, we adopted a longitudinal observational
design, with data collected at two time points from a large
international cohort of people with MS. This enabled a
prospective examination of the associations between lifestyle
risk factors at baseline and HRQOL at the follow-up. To
investigate aggregated lifestyle patterns in people with MS, we
first generated a healthy lifestyle index score that consisted of
the five modifiable-lifestyle risk factors—physical activity, dietary
habits, BMI, alcohol consumption, and smoking—modeled on
previous scores used in cancer research (16, 17). We then
explored the prospective association of this index score at
baseline with physical and mental health HRQOL over the study
period in this sample of people with MS.
METHODS
Participants and Recruitment
This research involved the analysis of a large international sample
of longitudinal data in people with MS who were followed up
over a 2.5-year timeframe after baseline surveys undertaken
in 2012. The methodology, participant demographics and
inclusion/exclusion criteria have been detailed previously (18).
In brief, in a general invitation, participants were recruited from
MS societies’ websites, MS blogs and social media. Participants
with self-reported formally diagnosed MS were encouraged to
take part. Respondents under 18 years of age were excluded.
Data Collection
An online survey platform, SurveyMonkeyTM was used to
conduct the survey. Participants read an information sheet before
giving consent for continuing the survey. Contact details were
recorded to facilitate follow-up. Multiple email reminders were
sent to maximize follow-up and for those participants without a
valid email address, contact was attempted through alternative
means (e.g., Facebook, phone).
The comprehensive online survey consisted of 100 major
items at baseline and 111 major items at 2.5 year follow-up
and took approximately 40min to complete. All data were self-
reported and stored in a re-identifiable form. Specific items
exploring the combined effect of lifestyle risk factors including
dietary habits, BMI, physical activity, alcohol consumption, and
smoking on the outcome HRQOL were included. Other variables
relevant to the analyses were also included, such as gender, age,
education, use of disease modifying drugs (DMD) and Patient-
Derived MS Severity Score (P-MSSS). Details of these measures
are described below.
Age
Participants’ ages at 2.5 year follow-up were used and calculated
with date of birth and date of survey completed.
Education
Participants’ education levels were categorized into two
categories: (a) No formal education or primary school; and (b)
secondary school or above.
DMD Use
Participants were categorized as either (a) currently using DMD
(within a provided list of 24 DMDs) or (b) not currently
using DMD.
P-MSSS
The P-MSSS is an algorithm derived from adjusting disease
duration and mean ranks of the Patient-Determined Disease
Steps (PDDS) (19). The PDDS is a validated patient-reported
outcome of disability in MS focusing mainly on the walking
ability of the person and has been shown to correlate with the
Expanded Disability Status Scale (EDSS) (20).
Dietary Habits
Diet quality at the time of the data collection was assessed using a
modified version of the Diet Habits Questionnaire (DHQ) (21).
It was modified from the original 24-item dietary assessment
tool that assesses the type and quality of fat intake and fiber,
fruit, vegetable and omega-3 consumption. One item related to
alcohol and three items on sodium intake were removed. The
rationale for removing these items was that alcohol wasmeasured
separately in the survey and sodium intake was not considered
a major influence at the time of the baseline survey. A total
DHQ score was calculated from the 20-item questionnaire by
giving equal weight to all items. Higher scores indicated healthier
dietary behavior. The original 24-item tool has been validated in
an Australian cardiac disease population (21).
BMI
BMI was assessed according to the World Health Organization
criteria and defined as a person’s weight in kilograms divided by
their squared height in meters (kg/m2), and was categorized as
defined a priori (17).
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Physical Activity
Physical activity was assessed with the International Physical
Activity Questionnaire Short Form (IPAQ-SF) (22) which
measures the frequency and duration of physical activity
participation in the past 7 days. A combined total score can be
computed to metabolic equivalent of task (MET) minutes per
week which has been validated in MS populations (23). Higher
values indicated more active lifestyle behavior.
Alcohol Consumption
Alcohol consumption was measured by frequency and volume
in standard drinks. Participants were advised on the study’s
definition of standard drinks which was equivalent to 10 g of
ethanol. This definition included the following examples: one
glass of full strength beer (285ml); two 285ml glasses of low
strength beer; one 100ml glass of wine; or 30ml nip or equivalent
of mixed spirits. The frequency of alcohol use was collected on
an 11-point scale (“never drink” to “drink daily”) and collapsed
to a 5-point scale (non-drinker, rarely, <1/week, 1 day/week
to 3 days/week, 4 days/week to daily). The volume of alcohol
consumption was collected on an 11-point scale (“not applicable”
to “10+ standard drinks per day”). Data were then re-calculated
to average daily ethanol consumption in grams.
Smoking
Smoking was assessed by smoking status (never, current,
previous); frequency of smoking among current smokers (15 or
less cigarettes per day, or more than 15); and time since quitting
among former smokers (10 or more years, or less than 10).
Health-Related Quality of Life
HRQOLwas assessed using theMultiple Sclerosis Quality of Life-
54 questionnaire (MSQOL-54) that was developed from the 36-
Item Short Form Health Survey (SF-36) supplemented with 18-
items relevant to MS. The MSQOL-54 produces two composite
scores for physical health (PHC) and mental health (MHC)
determined from a weighted sum of selected subscale scores (24).
PHC consists of eight sub-domains namely, physical function,
health perceptions, fatigue/energy, physical role limitations,
pain, sexual function, social function, and health distress.
MHC consists of five sub-domains, namely, cognitive function,
emotional role limitations, emotional well-being, health distress,
and overall quality of life. Higher scores indicate better quality
of life. The questionnaire has been extensively validated with
high reliability and strong construct validity across different
populations of people with MS (25–27).
Index Construction
In order to quantify the combined impact of lifestyle risk factors,
(a) dietary habits, (b) physical activity, (c) alcohol consumption,
(d) smoking, and (e) BMI were collected from the data to
create a healthy lifestyle index score (HLIS). “Healthier” and
“less healthy” behaviors for each lifestyle risk factor in the
HLIS were defined a priori (17). The cut-offs used along with
the modifications are described in detail in the proceeding
paragraphs.
The HLIS was constructed from the sum of five lifestyle risk
factor component scores by assigning a 5-category score (0 to 4)
to each component. The overall health index ranged from 0 to
20, with higher values indicating adherence to a greater number
of healthy lifestyle behaviors.
The score for diet was generated by categorizing the values
of total DHQ score for the participants into five quintiles. This
means that the highest 20% of answers were assigned with the
highest score, four, and the lowest 20% answers with the lowest
score, zero. The lowest score was defined as having less than 68 in
total DHQ score. A score of one was generated for those with 68
to less than 77; a score of two for those with 77 to less than 84; a
score of three for those with 84 to less than 91; and a score of four
for those with 91 to 100 in total DHQ score.
For BMI, the lowest score, zero, was generated for those with
BMI greater than 29, a score of one for BMI between 26 to less
than 29; a score of two for BMI between 24 to less than 26, a score
of three for BMI between 22 to less than 24; and a score of four
for BMI less than 22.
For physical activity, the total MET minutes per week were
converted to MET hours per week. The lowest score for physical
activity was defined as undertaking less than 45 MET hours per
week. Other physical activity quintile scores were defined as (1):
between 45 to less than 69 MET hours per week; (2): between 69
to less than 96 MET hours per week; (3): between 96 to less than
134 MET hours per week; and (4): more than 134 MET hours
per week.
The healthiest behavior for smoking was defined as “never
smoked,” which was assigned a HLIS score of 4. Other categories
were defined as (0): current smokers who smoked more than 15
cigarettes per day; (1): current smokers who smoked less than or
equal to 15 cigarettes per day; (2): ex-smokers who quit less than
10 years ago; and (3): ex-smokers who quit 10 years or more ago.
For alcohol consumption, a score of 0 was assigned to those
consuming an average of greater than or equal to 20 (g/day) of
ethanol; a score of 1 was assigned to consuming greater than or
equal to 10.0- and less than 20 (g/day); a score of 2 was assigned to
consuming an average of greater than or equal to 5 and less than
10 (g/day); a score of 3 was assigned to consuming an average of
more than 0 and less than 5 (g/day); and a score of 4 was assigned
to those reporting no alcohol consumption.
Ethics
The original research received ethics approval from the
University of Melbourne (HEAG ID: 1545102) and St Vincent’s
Hospital Melbourne Human Research Ethics Committee
(LRR055/12).
Data Analysis
Data were analyzed using Stata, version 13 (StataCorp, College
Station, TX, USA). We provided descriptive characteristics
of included variables. Continuous variables were summarized
using mean and standard deviation and skewed data were
presented using median and interquartile range. Categorical
variables were summarized using frequency and percentages.
For each mental and physical HRQOL component, using linear
regression models, we presented an overall prospective analysis.
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We looked at prospective associations between baseline HLIS and
2.5 year HRQOL with and without adjustment for covariates, but
adjusting for baseline HRQOL, and therefore exploring whether
the baseline HLIS is associated with the change in HRQOL from
baseline to 2.5 years. We identified our covariates a priori, using
expert subject-matter knowledge based on previous literature
(9–12, 28). Using likelihood ratio tests, the assumptions of linear
associations between the continuous measures and the outcomes
were tested by comparing regression models with categorical
(quartile groupings) and pseudo-continuous variables. Analyses
were restricted to those with self-reported doctor-diagnosed MS
at baseline and complete-case analysis was used (i.e., restricted to
participants with complete data). The impact of complete drop-
out at follow-up was investigated using summary statistics based
on the baseline characteristics of those missing at follow-up.
Additional Analyses of a Modified and a
Rescaled Index
Although the exact potential protectivemechanism of alcohol use
is unclear, several other studies have observed this U or J-shaped
association with disability and HRQOL in people with MS (12,
29), as well as with cardiovascular health and total mortality
(30, 31). Moderate use of alcohol has also been observed to be
associated with a reduction in systemic inflammation (32). AsMS
has been widely seen as an autoimmune inflammatory disease
(33), moderate alcohol usage may potentially positively impact
on immune function. As there is no clear evidence for or against
moderate alcohol intake in people with MS, two additional
analyses were undertaken to investigate the associations of (i) a
modified and (ii) a rescaled version of the original HLIS with
HRQOL in this cohort of people with MS. In the modified HLIS,
a moderate consumption of alcohol (5.0 to <10 g/day) was
assigned with the highest component score of four, while those
who never consumed alcohol were assigned with a score of two
and highest alcohol consumption (>20 g/day) was assigned with
a score of zero. In the rescaled HLIS, the alcohol consumption
in the original HLIS was completely removed and the index was
rescaled.
RESULTS
Of 2,466 respondents with confirmed MS, 1401 (56.9%)
completed the survey at follow-up. Comparisons between the
baseline and follow-up data are shown in Table 1. Of the
1,401 completers, 995 (71.0%) responded to items regarding
lifestyle risk factors, allowing the generation of HLIS. The mean
HLIS for these participants was 10.2 of a possible total of
20 (SD = 3.4) (Table 1). The distribution of HLIS score is
presented in a histogram for respondents at baseline and at 2.5
years (Supplementary Figure 1). With regards to HRQOL, 1,358
(96.9%), and 1,316 (94.0%) completed responses for PHC and
MHC respectively. The mean PHC and MHC scores were 60.9
(SD= 34.3) and 70.3 (SD= 20.4) respectively (Table 1).
The results of the regression analyses on those who completed
the follow-up survey are summarized in Table 2 for the physical
health and mental health components. HLIS was included
as a continuous term rather than a categorical term in our
models as no evidence for non-linearity was found in the
association between HLIS and the outcome (likelihood ratio
test p-values >0.2). A total of 1,105 (∼79%) and 1,072 (∼77%)
respondents who had complete information on covariates and
HRQOL composite scores were included in the multivariable
regression models for PHC and MHC respectively.
Physical Health Composite
A strong positive association of HLIS with PHC was observed.
Every 5-point increase in the HLIS at baseline was associated 1.7
(95%CI: 0.2–3.2) higher scores in the change in physical HRQOL
component from baseline to follow-up. Models were adjusted for
age, gender, education, P-MSSS, and DMD use.
Mental Health Composite
HLIS also had strong positive associations with the mental health
composite of MSQOL-54. Every 5-point increase in the baseline
HLIS was associated with 2.5 (95% CI: 1.0–4.0) higher scores
in the change in mental HRQOL component from baseline
to follow-up. Models were adjusted for age, gender, education,
P-MSSS, and DMD use.
Additional analyses of the associations between original
HLIS and the two HRQOL composite scores are presented in
Supplementary Table 1. Compared to the original HLIS, for
PHC, similar effect sizes were observed using modified HLIS,
however the effect size attenuated when the rescaled HLIS
with the complete removal alcohol consumption was used.
For MHC, a slightly larger effect size was observed using the
modified HLIS, however the effect size stayed similar when
the rescaled HLIS was used. For completeness, we presented
baseline characteristics of completers and non-completers at
follow-up in Supplementary Table 2. A detailed comparison of
these characteristics has been described elsewhere (34), where
it has been shown that the completion of the 2.5-year wave is
associated with healthier lifestyle and better health outcomes.
In Supplementary Table 3, we have also presented baseline
characteristics according to baseline HLIS quartiles. Compared
to people with MS in the first quartile, those in the fourth quartile
tend to be younger and have lower disease severity.
DISCUSSION
Summary of Main Findings
Our data, based on a large international cohort, predominantly
Western and English-speaking people with MS, revealed strong
longitudinal associations between healthier lifestyle and better
HRQOL in terms of physical and mental health composite scores
of the MSQOL-54. This is the first longitudinal study to explore
the effect of aggregated lifestyle risk factors on HRQOL in
people with MS. Overall, the study participants appeared to have
moderately healthy lifestyle, as indicated by the mean scores on
the modified HLIS (Table 1, Supplementary Figure 1).
Our focus on HRQOL may be considered a strength of the
study. Due to the incomplete reflection of disease burdens by
traditional clinical endpoints such as physical disability, HRQOL
has gained increasing clinical importance in MS management
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TABLE 1 | Summary statistics of relevant variables.
Longitudinal data
Variable Category or
numerical range
Definition Baseline (n = 2466) 2.5 years (n = 1401)
number Percentage (%)
or mean (SD)
number Percentage (%)
or mean (SD)
Diet 0 1st quintile (< 68) 445 18.05 252 17.99
1 2nd quintile (68 to <77) 486 19.71 266 18.99
2 3rd quintile (77 to <84) 470 19.06 246 17.56
3 4th quintile (84 to <91) 439 17.80 286 20.41
4 5th quintile (91 to 100) 453 18.37 282 20.13
Missing Missing value 173 7.02 69 4.93
BMI 0 5th quintile (>29) 554 22.47 297 21.20
1 4th quintile (26 to <29) 314 12.73 176 12.56
2 3rd quintile (24 to <26) 345 13.99 204 14.56
3 2nd quintile (22 to <24) 448 18.17 270 19.27
4 1st quintile (<22) 772 31.31 449 32.05
Missing Missing value 33 1.34 5 0.36
Physical activity 0 1st quintile (<45 METs/wk) 1518 61.56 937 66.88
1 2nd quintile (45 to <69) 228 9.25 136 9.71
2 3rd quintile (69 to <96) 134 5.43 78 5.57
3 4th quintile (96 to <134) 85 3.45 38 2.71
4 5th quintile (>134) 106 4.30 53 3.78
Missing Missing value 395 16.02 159 11.35
Alcohol 0 1st quintile (≥20 g/day) 143 5.80 79 5.64
1 2nd quintile (≥10 – <20) 229 9.29 126 8.99
2 3rd quintile (≥5.0 – <10) 882 35.77 102 7.28
3 4th quintile (>0 – <5) 571 23.15 567 40.47
4 5th quintile (Never) 313 12.69 197 14.06
Missing Missing value 328 13.30 330 23.55
Smoking 0 1st quintile (current >15 cigs per day) 86 3.49 33 2.36
1 2nd quintile (current ≤15) 193 7.83 62 4.43
2 3rd quintile (ex-smoker quit <10 years) 450 18.25 204 14.56
3 4th quintile (ex-smoker quit ≥10 years) 449 18.21 317 22.63
4 5th quintile (never) 1099 44.57 701 50.04
Missing Missing value 189 7.66 84 6.00
Education Secondary school or above 2397 97.20 1371 97.86
No formal education or primary school only 55 2.23 10 0.71
Missing value 14 0.57 20 1.43
Gender Male 415 16.83 241 17.20
Female 1937 78.55 1150 82.08
Missing value 114 4.62 10 0.71
Current DMD use Yes 1145 46.43 589 42.04
No 1321 53.57 812 57.96
Missing value 0 0.00 0 0.00
Country Of Birth Australasia 682 27.66 464 33.12
Europe 778 31.55 445 31.76
North America/Caribbean 881 35.73 412 29.41
Other 117 4.74 62 4.43
Missing 8 0.32 18 1.28
Employment Work or studying 1416 57.42 787 56.17
Stay at home parent/carer 183 7.42 88 6.28
Unemployed 208 8.43 85 6.07
(Continued)
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TABLE 1 | Continued
Longitudinal data
Variable Category or
numerical range
Definition Baseline (n = 2466) 2.5 years (n = 1401)
number Percentage (%)
or mean (SD)
number Percentage (%)
or mean (SD)
Retired 647 26.24 415 29.62
Unspecified 2 0.08 3 0.21
Missing 10 0.41 23 1.64
Disease duration
since diagnosis
Range = 0.14 to
42.68
Disease duration since diagnosis 2437 8.07 (7.34) 1401 10.24 (7.07)
Age Range = 17 to 82 Age for longitudinal group 2428 45.69 (10.48) 1401 48.36 (10.50)
MS Severity
(P-MSSS)
Range = 0.42 to
9.98
MS severity scale calculated with years
since symptom onset and PDDS
2268 5.01 (2.75) 1352 5.01 (2.73)
HLIS Range = 0 to 20 The overall HLIS for longitudinal group 1913 10.15 (3.35) 995 10.88 (3.23)
PHC Range = 0 to 100 Physical health composite score for
MSQOL-54
2356 59.70 (33.27) 1358 60.91 (34.34)
MHC Range = 0.75 to
100
Mental health composite score for
MSQOL-54
2270 66.68 (21.35) 1316 70.34 (20.38)
TABLE 2 | Associations between baseline HLIS with Physical Health Composite and Mental Health Composite.
Baseline variables Physical health composite Mental health composite
Model 1# Model2## Model 1* Model2**
Mean difference
(95% CI)
p-value Mean difference
(95% CI)
p-value Mean difference
(95% CI)
p-value Mean difference
(95% CI)
p-value
HLIS 1.61 (0.12, 3.10) 0.03 1.68 (0.22, 3.15) 0.02 3.18 (1.69, 4.66) <0.001 2.54 (1.04, 4.04) 0.001
Age −0.02 (−0.29, −0.11) <0.001 −0.22 (−0.31, −0.12) <0.001 −0.10 (−0.19, −0.02) 0.02 −0.05 (−0.14, 0.04) 0.26
Female gender 0.24 (−2.06, 2.55) 0.84 −0.30 (−2.72,2.12) 0.81 −0.18 (−2.47, 2.11) 0.88 0.37 (−2.05,2.78) 0.77
Secondary or higher
education
−2.27 (−11.51,6.96) 0.63 1.92 (−9.66,13.50) 0.75 8.67 (−1.11,18.45) 0.08 2.99 (−8.48,14.46) 0.61
P-MSSS −1.63 (−2.12, −1.15) <0.001 −1.48 (−2.00, −0.96) <0.001 −0.66 (−0.99, −0.33) <0.001 −0.55 (−0.91, −0.82) 0.003
DMD use 1.27 (−0.50, 3.03) 0.16 2.36 (0.48, 4.24) 0.01 0.56 (−1.18, 2.31) 0.53 0.97 (−0.93, 2.86) 0.32
#Individual associations adjusted for baseline Physical Health Composite only.
##Associations adjusted for the covariates presented in the table and the baseline Physical Health Composite. Complete-case analysis: Physical Health Composite: N = 1,105.
*Individual associations adjusted for baseline Mental Health Composite only.
**Associations adjusted for the covariates presented in the table and the baseline Mental Health Composite. Complete-case analysis: Mental Health Composite: N = 1,072.
(35, 36). Indeed, MS poses significant psychological strains which
are often overlooked and undertreated (37). The use of HRQOL
provides a more sensitive indication of overall wellbeing and
enables better disease management. HRQOL has been designated
as an important outcome for treatment of chronic diseases by the
World Health Organization (38). Overall, HRQOL is a valuable
measure that is a major outcome for intervention programs to
target.
Although potentially difficult to change, most lifestyle risk
factors can be modified. Modifiable risk factors such as higher
body mass index (BMI), serum lipid profile and smoking
have been found to be associated with a more rapid rate of
disability progression (39, 40). Consolidated recent evidence
(41) highlights the important role of modifiable risk factors and
presents opportunities for intervention programs to improve
diseasemanagement and secondary prevention ofMS. It has been
shown that common lifestyle risk factors cluster among adults
in the general population and this tendency for risk factors to
aggregate can have important implications for health promotion
(42). While for several high-burden diseases such as colorectal
cancer and breast cancer, the impact of aggregated lifestyle factors
on health outcomes has been explored previously (16, 17), no
study to date has investigated this in people with MS. This
research attempts to fill a gap in the MS literature where there is a
need for longitudinal studies of people withMS where aggregated
modifiable lifestyle risk factors can be explored to provide
more informative epidemiological findings and translation to
preventive interventions in randomized controlled trials.
Limitations
Nonetheless, our findings had several limitations. First, our
complete case analyses were based on the assumption that data
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were missing completely at random. The comparison of baseline
characteristics for those who did not complete to those that
completed the follow-up suggested that this may not be a realistic
assumption. There seem to be a higher proportion of participants
who did not complete the follow-up at relatively lower levels
of HLIS (less healthy) (See Supplementary Table 1). However,
in this study, we lack auxiliary variables—the variables that are
highly correlated with the variables with missing values, but are
not in the analysis model of interest. In this setting, we are
less likely to gain information about the exposure and outcome
association from approaches to handling missing values such
as multiple imputation, given that the missing values are in
our outcome variables (43). Imputation approaches can result
in biased inference if not carried out appropriately or if the
underlying assumptions are not justifiable (44). Further, this
cohort was recruited through an online methodology which
may not reflect health behaviors in the general population of
people with MS. For example, differences in health behaviors
were identified when comparing our study findings to a survey
from the North American Research Committee on Multiple
Sclerosis Registry (45). Our study participants from both
cohorts appeared to be moderately healthy, yet survey results
from the registry suggested otherwise (45). This could imply
disproportionate lifestyle risk factors between respondents and
the general population of people with MS. As such, non-response
or participation bias limits the generalizability of our findings to
the global community of people with MS.
In our sample, those that did not complete the follow-up
were more likely to have missing responses at baseline (See
Supplementary Table 2). This could imply those that were lost
to follow-up may have had little interest in health while those
completing follow-upmay have beenmore health-conscious. It is
possible that the health-conscious respondents were more likely
to report healthier lifestyle behaviors. The accuracy of our data
may have been affected as all of the responses were self-reported.
Although most of the variables were measured with validated
tools, the lack of verification regarding diagnosis of participants
can still affect, to some extent, the reliability of our data. Some
of the variables were also hard to measure. Particularly, when
respondents were asked to recall certain information such as
dietary habits, the amount of alcohol consumption and duration
of physical activity in the past 7 days. In addition, our data
may also have been affected by social desirability bias, as the
participants may tend to overreport healthier behaviors and
underreport detrimental behaviors.
The range of lifestyle behavior measured in the original study
was based on existing literature that support the relationships
with MS health outcomes. However, due to the limitation of
using pre-existing data from the original study, we were unable
to include additional or alternative information that could have
been relevant to our study. For instance, sodium intake was
excluded from the DHQ questionnaire, yet the relationship
between consumption of sodium and disease progression in
people with MS is unclear. One observational study found
positive associations (higher intake in sodium correlated with
increased disease activity in people with MS) (46) while
another found no associations (47). The exclusion of sodium
intake could have affected the estimated associations in both
directions. In addition, the questionnaire assigned margarine use
with favorable scoring, for example. Margarine is a source of
industrially produced trans fatty acids (48) and trans fatty acids
have been reported to be associated with up-regulation of pro-
inflammatory cytokines (49). As elevation of these cytokines is
evident in the involvement of MS disease activity, the favorable
scoring for margarine use should be reconsidered when using
the DHQ in people with MS (50). Consequently, the lack of
robustness of the questionnaire; its lack of validation in MS
populations; and its applicability across ethnic diversities limit
the strength of our findings on the contribution of diet to health
outcomes in people with MS.
Similar issues can be found in the assessment of physical
activity with HRQOL. It is possible that certain types or
intensities of physical activity have different effects in people with
different levels of disability. However, the instrument (IPAQ-SF)
used to measure physical activity in people with MS lack the
relevant measurement of an individual’s ability to participate in
physical activity, and it cannot be concluded that which form of
physical activity is most beneficial to people with MS.
The construction of HLIS also has its limitations. In the
HLIS, different lifestyle risk factors were weighted equally. The
choice is an imperfect estimation that each lifestyle behavior
has equal impact on HRQOL. In addition, for the purpose of
this study, we adhered to the original cut-off points whenever
possible. The cut-off thresholds for physical activity were pre-
defined from a very large sample (n = 242, 918) of menopausal
women (17). However, the top quintiles of physical activity may
not be achievable by the general MS population. This is because
the level of physical activity depends on the level of disability,
and people with MS are often affected by symptoms such
as pain which prevents participation in physical activity (51).
Finally, former smoking behavior is a past event. This implies
that the HLIS has limited power to reflect on the combined
impact of modifiable risk factors, but rather, only on lifestyle risk
factors.
Recommendations and Implications
In light of these limitations, several recommendations for
future studies can be made. Interviewer-administered 24-h
recall in future assessment may be incorporated to measure
usual frequency in physical activity, food and fluid intakes.
Better validation of the DHQ tool on the MS population or
using a more comprehensive tool for the assessment of diet
on MS morbidity may also be useful. While having a more
comprehensive tool allows better capture on the complexities
of lifestyle patterns, it also imposes a burden to survey
respondents. In order to reduce drop out or non-response
bias, it is important to keep a balance between concise and
comprehensive questionnaires. By minimizing these biases, more
accurate assessments of lifestyle risk factors may be obtained
which can be crucial for advancing the internal validity of the
study.
Future studies can also seek to validate the positive
associations we have seen in this study on a general population
of people with MS. More studies are warranted to investigate
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the causal relationship between HLIS and HRQOL in people
with MS. In particular, randomized controlled trials could
be undertaken in order to examine this issue. More studies
are also required to understand the underlying biological
mechanisms between different lifestyle behaviors, complex
interplay between the constructs of HLIS and other variables
(52) and HRQOL, thereby allowing the examination of
potential influence of different weightings in the construction of
HLIS.
Nonetheless, this study highlights the importance of lifestyle
behaviors on HRQOL in people with MS. This provides
opportunities for future targeted lifestyle interventions to
improve the morbidity of people with MS.
CONCLUSIONS
Healthier lifestyle behavior is associated with better mental and
physical health related quality of life in this longitudinal sample
of people with MS. These findings are highlight the importance
of health promotion programs to improve chronic disease
management in people with MS, as in other chronic diseases.
Further research is needed to establish causal relationships as well
as predicting changes in HRQOL throughout the course of MS.
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